EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Minimising Risk and Maximising Efficiency by taking a Strategic Approach to Comparative Trial Supply

Widely acknowledged to be a prerequisite for formulary listing and even successful licensure, comparator drugs and co-therapies are used within an estimated two-thirds of clinical trials. Nicholas Griffin at Almac Clinical Services evaluates how to minimise risk and increase efficiency when taking a strategic approach to comparative trial supply.

 

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18